
John Sampson MD PhD, MBA
Brain & Spinal Tumor
Department Chair, Duke Neurosurgery
Join to View Full Profile
12605 E 16th AveAurora, CO 80045
Phone+1 720-848-0000
Dr. Sampson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Large research focus on immunotherapy for high grade glioma.
Education & Training
Duke UniversityMBA, 2011
Duke UniversityMHSc, 2007
Duke University HospitalResidency, Neurological Surgery, 1991 - 1998
Duke University HospitalInternship, Transitional Year, 1990 - 1991
University of ManitobaClass of 1990
Certifications & Licensure
CO State Medical License 2024 - 2027
NC State Medical License 1996 - 2026
FL State Medical License 2014 - 2022
American Board of Neurological Surgery Neurological Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- 1 citationsProton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma.Emilie Le Rhun, Debaleena Sain, Sara C Erridge, David A Reardon, Giuseppe Minniti
JAMA Network Open. 2025-11-03 - 4 citationsA peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.Eric M Thompson, David M Ashley, Katayoun Ayasoufi, Pamela Norberg, Gerald Archer
Nature Cancer. 2025-09-01 - Advances in neuro-oncology: contributions of the Asilomar Conference on brain tumor research and therapy.Manfred Westphal, Victor A Levin, Mitchel S Berger, Russell Pieper, Ryo Nishikawa
Journal of Neurosurgery. 2024-12-20
Journal Articles
- Sequestration of T Cells in Bone Marrow in the Setting of Glioblastoma and Other Intracranial TumorsPeter E Fecci, Cosette A Dechant, Robert L Martuza, Karolina Woroniecka, Brian V Nahed, James E Herndon, William T Curry, Aladine A Elsamadicy, John H Sampson, Michael..., Nature
- Complete response to steroids in dural inflammatory pseudotumor associated with Still's diseaseBatich, K.B., St. Clair, E.W., McLendon, R.E., Sampson, J.H., J Clin Neurosci, 10/1/2013
- Isocitrate dehydrogenase 1 (IDH1): What it means to the neurosurgeonHodges, T.R., Choi, B.D., Bigner, D.D., Yan, H., Sampson, J.H., J Neurosurg, 6/1/2013
Books/Book Chapters
Abstracts/Posters
- Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma.Cuneo, K.C., Cabrera, A.R., Sampson, J.H., Allen, K.J., Vredenburgh, J.J., Peters, K., Chang, Z., Herndon, J.E., Desjardins, A., Reardon, D.A., Kirkpatrick, J., J Clin Oncol, 1/1/2011
- Concurrent Bevacizumab and Radiosurgery for Recurrent Malignant Glioma: Toxicity Results from a Prospective Pilot Study.Cuneo, K.C., Cabrera, A.R., Sampson, J.H., Allen, K., Duffy, E., Vredenburgh, J.J., Peters, K.B., Chang, Zheng, Desjardins, A., Kirkpatrick, J.P., ASTRO, Int J Radiat Oncol Biol Phys, 1/1/2011
- Dendritic cell vaccines targeting cytomegalovirus in glioblastoma.Mitchell, D.A., Archer, G.E., Friedman, H.S., Herndon, J.E., Bigner, D.D., Sampson, J.H., 16th Annual Society for Neuro-oncology meeting, Neuro-oncol, 1/1/2011
Lectures
- Chimeric Antigen Receptor (CAR) and Adoptive Cell Transfer2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018
- Novel role for enhancing immunotherapy against pediatric brain tumors using hematopoietic stem cells.San Francisco, CA - 11/21/2013
- Developmentally regulated antigens for immunologic targeting of medulloblastoma subtypes.San Francisco, CA - 11/21/2013
Other
- Novel Therapies in the Management of Malignant Brain Tumors: Bevacizumab and Surgery.Chang, S., Sampson, J.H., Aghi, M., Theodosopoulos, P.V., CNS Neurosurger Webinars, Controversies in Neuro-Oncology: An Academic- Community Forum
1/12/2010 - Cell-mediated immunotherapy of brain tumors.Sampson, J.H., Doctoral Thesis Defense, Duke University
12/5/1996
Press Mentions
CU Anschutz Innovations and Medtronic Forge Strategic Research Agreement to Drive Healthcare InnovationJanuary 22nd, 2026
Historic $40 Million Gift to CU Anschutz Department of Ophthalmology Will Fuel Research and New TherapiesJune 3rd, 2025
A Year of Research Momentum and New OpportunitiesDecember 16th, 2024
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









